aldosterone has been researched along with icatibant in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anania, V; Demontis, MP; Fattaccio, MC; Glorioso, N; Madeddu, P; Pinna-Parpaglia, P; Varoni, MV | 1 |
Beierwaltes, WH; Carretero, OA; Rudichenko, VM | 1 |
Bischoff, A; Michel, MC | 1 |
Brown, NJ; Kumar, S; Murphey, LJ | 1 |
1 trial(s) available for aldosterone and icatibant
Article | Year |
---|---|
Endogenous bradykinin and the renin and pressor responses to furosemide in humans.
Topics: Adrenergic beta-Antagonists; Adult; Aldosterone; Blood Pressure; Bradykinin; Creatinine; Cross-Over Studies; Diuretics; Female; Furosemide; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Potassium; Pressoreceptors; Receptor, Bradykinin B2; Receptors, Bradykinin; Renin; Single-Blind Method; Sodium | 2000 |
3 other study(ies) available for aldosterone and icatibant
Article | Year |
---|---|
Chronic inhibition of bradykinin receptors alters cardiovascular function in rats with an excess of circulating vasoconstrictors.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Cardiovascular Physiological Phenomena; Corticosterone; Kinins; Rats; Rats, Wistar; Time Factors | 1994 |
Neither endogenous nor exogenous bradykinin stimulates aldosterone in vivo.
Topics: Aldosterone; Animals; Aorta; Bradykinin; Diet, Sodium-Restricted; Dose-Response Relationship, Drug; Injections, Intra-Arterial; Male; Rats; Rats, Sprague-Dawley | 1993 |
Neuropeptide Y enhances potassium excretion by mechanisms distinct from those controlling sodium excretion.
Topics: Aldosterone; Animals; Bradykinin; Humans; Indomethacin; Losartan; Male; Neuropeptide Y; Nifedipine; Potassium; Rats; Rats, Wistar; Sodium | 2000 |